Evidence map›Paper›PMID 19144808›Full record

ArticleJournal of clinical microbiology2009

Internal control for nucleic acid testing based on the use of purified Bacillus atrophaeus subsp. globigii spores.

François J Picard, Martin Gagnon, Marthe R Bernier, Nicholas J Parham, Martine Bastien, Maurice Boissinot, Régis Peytavi, Michel G Bergeron

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A novel method for rapid and sensitive detection of viable Escherichia coli cells using UV-induced PMA-coupled quantitative PCR.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

François J PicardCentre de Recherche en Infectiologie de l'Université Laval, Centre Hospitalier Universitaire de Québec (Pavillon CHUL), Québec, Québec, Canada.
Martin Gagnon
Marthe R Bernier
Nicholas J Parham
Martine Bastien
Maurice Boissinot
Régis Peytavi
Michel G Bergeron

Funding

Microfluidic system for point of care diagnosis of GBSU01AI060594 · NIAID · LAVAL UNIVERSITY · PI BERGERON, MICHEL G. · 2004 to 2008
$2.6M
NIAID NIH HHS 1 U01 AI060594-01NIAID NIH HHS U01 AI060594
6 · The paper itself

Abstract

Commonly used internal controls (ICs) to monitor the efficiency of nucleic acid testing (NAT) assays do not allow verification of nucleic acid extraction efficiency. Since microbial cells are often difficult to lyse, it is important to ensure that nucleic acids are efficiently extracted from any target organism. For this purpose, we developed a cellular IC based on the use of nonpathogenic Bacillus spores. Purified Bacillus atrophaeus subsp. globigii (referred to hereafter as simply B. atrophaeus) spores were added to vaginal and anal samples, which were then subjected to rapid DNA extraction and subsequent PCR amplification. The proof of concept of this cellular IC was made through the use of both manual and automated DNA extraction methods, using vaginal or anal samples spiked with B. atrophaeus spores, combined with a multiplex real-time PCR assay for the specific detection of group B streptococci (GBS) and B. atrophaeus. The performance of the cellular IC was compared to that of a standard IC plasmid added to PCRs. Approximately 500 B. atrophaeus spores per PCR was found to be optimal since this did not interfere significantly with GBS detection for either DNA extraction method and yielded reproducible amplification and/or detection of B. atrophaeus genomic DNA serving as an IC template. Performance of the cellular IC was comparable to that of the standard IC. This novel IC system using nonpathogenic and hard-to-lyse B. atrophaeus spores allowed validation of both the DNA extraction procedure and the amplification and detection process. Use of a spore-based control also provides a universal control for microbial cell lysis.

Indexed as

Anal CanalBacillusBacteriaDNA, BacterialFemaleHumansNucleic Acid Amplification TechniquesPolymerase Chain ReactionReference StandardsReproducibility of ResultsSpores, BacterialStreptococcal InfectionsStreptococcus agalactiaeVaginaDNA, Bacterial

Identifiers

PMID19144808
PMCPMC2650944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.